loadpatents
name:-0.051199913024902
name:-0.020930051803589
name:-0.021231889724731
de Haard; Hans Patent Filings

de Haard; Hans

Patent Applications and Registrations

Patent applications and USPTO patent grants for de Haard; Hans.The latest application filed is for "antibodies to human complement factor c2b and methods of use".

Company Profile
20.17.46
  • de Haard; Hans - Oudelande NL
  • DE HAARD; Hans - Zwijnaarde BE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Antibodies To Human Complement Factor C2b And Methods Of Use
App 20220267424 - Blanchetot; Christophe ;   et al.
2022-08-25
Anti-apoc3 Antibodies
App 20220251180 - DASILVA-JARDINE; Paul ;   et al.
2022-08-11
Anti-apoc3 Antibodies And Methods Of Use Thereof
App 20220220193 - DASILVA-JARDINE; Paul ;   et al.
2022-07-14
Antibodies To Human Complement Factor C2b And Methods Of Use
App 20220119509 - BLANCHETOT; Christophe ;   et al.
2022-04-21
Anti-ApoC3 antibodies
Grant 11,248,041 - DaSilva-Jardine , et al. February 15, 2
2022-02-15
Polynucleotides encoding anti-ApoC3 antibodies
Grant 11,248,042 - DaSilva-Jardine , et al. February 15, 2
2022-02-15
Anti-ApoC3 antibodies and methods of use thereof
Grant 11,242,381 - Dasilva-Jardine , et al. February 8, 2
2022-02-08
Anti-apoc3 Antibodies And Methods Of Use Thereof
App 20220025027 - DASILVA-JARDINE; Paul ;   et al.
2022-01-27
Anti-apoc3 Antibodies And Methods Of Use Thereof
App 20220025026 - DASILVA-JARDINE; Paul ;   et al.
2022-01-27
Anti-GARP protein
Grant 11,230,603 - Lucas , et al. January 25, 2
2022-01-25
Antibodies Specific For Human And Cynomolgus Apoc3 And Methods Of Use Thereof
App 20210347865 - DASILVA-JARDINE; Paul ;   et al.
2021-11-11
Antibodies that specifically bind to human complement factor C2b
Grant 11,161,900 - Blanchetot , et al. November 2, 2
2021-11-02
Galectin-10 Antibodies
App 20210332140 - PERCIER; Jean-Michel ;   et al.
2021-10-28
Anti-ApoC3 antibodies and methods of use thereof
Grant 11,091,539 - DaSilva-Jardine , et al. August 17, 2
2021-08-17
Galectin-10 antibodies
Grant 11,066,473 - Percier , et al. July 20, 2
2021-07-20
Anti-flt-1 Antibodies For Treating Duchenne Muscular Dystrophy
App 20210206860 - KEEFE; Dennis ;   et al.
2021-07-08
Amino Acid Sequences That Modulate The Interaction Between Cells Of The Immune System
App 20210139587 - Hermans; Guy ;   et al.
2021-05-13
Anti-flt-1 Antibodies In Treating Bronchopulmonary Dysplasia
App 20210130475 - KEEFE; Dennis ;   et al.
2021-05-06
Amino acid sequences that modulate the interaction between cells of the immune system
Grant 10,844,123 - Hermans , et al. November 24, 2
2020-11-24
Anti-Flt-1 antibodies for treating duchenne muscular dystrophy
Grant 10,787,515 - Keefe , et al. September 29, 2
2020-09-29
Antibodies To Human Complement Factor C2b And Methods Of Use
App 20200239554 - Blanchetot; Christophe ;   et al.
2020-07-30
Anti-apoc3 Antibodies And Methods Of Use Thereof
App 20200239555 - DaSilva-Jardine; Paul ;   et al.
2020-07-30
Anti-FLT-1 antibodies in treating bronchopulmonary dysplasia
Grant 10,711,065 - Keefe , et al.
2020-07-14
Anti-apoc3 Antibodies And Methods Of Use Thereof
App 20200216523 - DaSilva-Jardine; Paul ;   et al.
2020-07-09
Anti-garp Protein And Uses Thereof
App 20200181276 - Lucas; Sophie ;   et al.
2020-06-11
Anti-apoc3 Antibodies And Methods Of Use Thereof
App 20200148755 - DASILVA-JARDINE; Paul ;   et al.
2020-05-14
Antibody against a complex between human GARP and latent TGF-.beta.
Grant 10,604,579 - Lucas , et al.
2020-03-31
Compositions And Methods For Treating Immune Thrombocytopenia
App 20200024344 - de Haard; Hans ;   et al.
2020-01-23
Anti-APOC3 antibodies and compositions thereof
Grant 10,538,583 - DaSilva-Jardine , et al. Ja
2020-01-21
Galectin-10 Antibodies
App 20190367619 - PERCIER; Jean-Michel ;   et al.
2019-12-05
Anti-apoc3 Antibodies And Methods Of Use Thereof
App 20190241648 - DaSilva-Jardine; Paul ;   et al.
2019-08-08
Amino Acid Sequences That Modulate The Interaction Between Cells Of The Immune System
App 20190211101 - Hermans; Guy ;   et al.
2019-07-11
ANTI-Kv1.3 ANTIBODIES, AND METHODS OF PRODUCTION AND USE THEREOF
App 20190144538 - Colussi; Paul A. ;   et al.
2019-05-16
Anti-apoc3 Antibodies And Methods Of Use Thereof
App 20190135906 - DaSilva-Jardine; Paul ;   et al.
2019-05-09
Treatment For Acute Myeloid Leukemia
App 20190106498 - de Haard; Hans ;   et al.
2019-04-11
Amino acid sequences that modulate the interaction between cells of the immune system
Grant 10,208,115 - Hermans , et al. Feb
2019-02-19
Anti-garp Protein And Uses Thereof
App 20190016811 - Lucas; Sophie ;   et al.
2019-01-17
Garp-tgf-beta Antibodies
App 20180327487 - Van der Woning; Sebastian ;   et al.
2018-11-15
Amino acid sequences that modulate the interaction between cells of the immune system
Grant 10,087,251 - Hermans , et al. October 2, 2
2018-10-02
Anti-flt-1 Antibodies In Treating Bronchopulmonary Dysplasia
App 20180100017 - KEEFE; Dennis ;   et al.
2018-04-12
Anti-flt-1 Antibodies For Treating Duchenne Muscular Dystrophy
App 20180072806 - KEEFE; Dennis ;   et al.
2018-03-15
Pulmonary administration of immunoglobulin single variable domains and constructs thereof
Grant 9,725,522 - Bouche , et al. August 8, 2
2017-08-08
Single Domain Antibodies Directed Against Tumor Necrosis Factor-alpha And Uses Therefor
App 20170096481 - SILENCE; KAREN ;   et al.
2017-04-06
Amino Acid Sequences That Modulate The Interaction Between Cells Of The Immune System
App 20160289327 - Hermans; Guy ;   et al.
2016-10-06
Pulmonary Administration Of Immunoglobulin Single Variable Domains And Constructs Thereof
App 20160280799 - BOUCHE; MARIE-PAULE LUCIENNE ARMANDA ;   et al.
2016-09-29
Amino Acid Sequences That Modulate The Interaction Between Cells Of The Immune System
App 20160280786 - Hermans; Guy ;   et al.
2016-09-29
Anti-garp Protein And Uses Thereof
App 20160272717 - Lucas; Sophie ;   et al.
2016-09-22
Anti-garp Protein And Uses Thereof
App 20160251438 - Lucas; Sophie ;   et al.
2016-09-01
Single domain antibodies directed against tumor necrosis factor-alpha and uses therefor
Grant 9,371,381 - Silence , et al. June 21, 2
2016-06-21
Pulmonary administration of immunoglobulin single variable domains and constructs thereof
Grant 9,320,792 - Bouche , et al. April 26, 2
2016-04-26
Amino Acid Sequences That Modulate The Interaction Between Cells Of The Immune System
App 20150266958 - Hermans; Guy ;   et al.
2015-09-24
Single Domain Antibodies Directed Against Tumor Necrosis Factor-alpha And Uses Therefor
App 20150110782 - Silence; Karen ;   et al.
2015-04-23
Single Domain Antibodies Directed Against Tumor Necrosis Factor-alpha And Uses Therefor
App 20120202977 - Silence; Karen ;   et al.
2012-08-09
Single Domain Antibodies Directed Against Tumor Necrosis Factor-alpha And Uses Therefor
App 20110184150 - Silence; Karen ;   et al.
2011-07-28
Single Domain Antibodies Directed Against Tumor Necrosis Factor-alpha And Uses Therefor
App 20110027281 - Silence; Karen ;   et al.
2011-02-03
Anti-FC-receptor single domain antibodies (nanobodies-tm) and therapeutic use
App 20100136018 - Dolk; Edward ;   et al.
2010-06-03
Nanobodies and Polypeptides Against EGFR and IGF-IR
App 20090252681 - Laeremans; Toon ;   et al.
2009-10-08
Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
App 20090022721 - Silence; Karen ;   et al.
2009-01-22
Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
App 20070237769 - Silence; Karen ;   et al.
2007-10-11
Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
App 20070077249 - Silence; Karen ;   et al.
2007-04-05
Single domain antibodies directed against tumor necrosis factor alpha and uses therefor
App 20060034845 - Silence; Karen ;   et al.
2006-02-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed